DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
15 jun 2007 - 08:09
Statutaire naam
DSM B.V.
Titel
Partnering strategy for DSM Anti-Infectives
Bericht
• Carve-out of business group
• Impairment of some EUR 110 million net in Q2 2007
DSM today announces the outcome of the strategic review of its Anti-Infectives business.
DSM has studied all options and has concluded that the greatest value will be generated through a partnering strategy (possibly with - partial - divestments) for the business combined with innovation initiatives and further restructuring measures to improve profitability. As a result, DSM Anti-Infectives aims to report a sustainable profit as from 2008.
Gerelateerde downloads
Datum laatste update: 16 december 2025